Europe Viral-Vectored Vaccines Market Research Report Forecast 2017-2021

March 2017 | 105 pages | ID: E7304F26FE6EN
S&P Consulting

Abstracts

The Europe Viral-Vectored Vaccines Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Viral-Vectored Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Viral-Vectored Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Viral-Vectored Vaccines Market Analysis by Countries :

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

The Major players reported in the market include:
Bayer HealthCare AG (Germany)
Biogenesis-Bago (Argentina)
Boehringer Ingelheim GmbH (Germany)
Ceva Sante Animale (France)
Heska Corporation (US)

• Indian Immunologicals Ltd (India)

Lohmann Animal Health (US)
Merck Animal Health (US)
Merial Ltd. (US)
Europe Viral-Vectored Vaccines Market Analysis by Product :

• Type 1
• Type 2
• Type 3

Europe Viral-Vectored Vaccines Market Analysis by Application:

• Application 1
• Application 2
• Application 3

REASONS FOR BUYING THIS REPORT

This report provides pin-point analysis for changing competitive dynamics

• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 VIRAL-VECTORED VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Viral-Vectored Vaccines
1.2 Classification of Viral-Vectored Vaccines
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Viral-Vectored Vaccines
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Viral-Vectored Vaccines Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Viral-Vectored Vaccines (2012-2021)
  1.5.1 Europe Viral-Vectored Vaccines Sales and Growth Rate (2012-2021)
  1.5.2 Europe Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON VIRAL-VECTORED VACCINES INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 VIRAL-VECTORED VACCINES MANUFACTURING COST ANALYSIS

3.1 Viral-Vectored Vaccines Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Viral-Vectored Vaccines

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Viral-Vectored Vaccines Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE VIRAL-VECTORED VACCINES MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Viral-Vectored Vaccines Market Competition by Manufacturers
  5.1.1 Europe Viral-Vectored Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Viral-Vectored Vaccines Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Viral-Vectored Vaccines (Volume and Value) by Type
  5.2.1 Europe Viral-Vectored Vaccines Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Viral-Vectored Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Europe Viral-Vectored Vaccines (Volume and Value) by Countries
  5.3.1 Europe Viral-Vectored Vaccines Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Viral-Vectored Vaccines Revenue and Market Share by Countries (2012-2017)
5.4 Europe Viral-Vectored Vaccines (Volume) by Application

6 GERMANY VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Viral-Vectored Vaccines Sales and Value (2012-2017)
  6.1.1 Germany Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  6.1.2 Germany Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Viral-Vectored Vaccines Sales Price Trend (2012-2017)
6.2 Germany Viral-Vectored Vaccines Sales and Market Share by Manufacturers
6.3 Germany Viral-Vectored Vaccines Sales and Market Share by Type
6.4 Germany Viral-Vectored Vaccines Sales and Market Share by Application

7 FRANCE VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

7.1 France Viral-Vectored Vaccines Sales and Value (2012-2017)
  7.1.1 France Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  7.1.2 France Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  7.1.3 France Viral-Vectored Vaccines Sales Price Trend (2012-2017)
7.2 France Viral-Vectored Vaccines Sales and Market Share by Manufacturers
7.3 France Viral-Vectored Vaccines Sales and Market Share by Type
7.4 France Viral-Vectored Vaccines Sales and Market Share by Application

8 UK VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

8.1 UK Viral-Vectored Vaccines Sales and Value (2012-2017)
  8.1.1 UK Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  8.1.2 UK Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  8.1.3 UK Viral-Vectored Vaccines Sales Price Trend (2012-2017)
8.2 UK Viral-Vectored Vaccines Sales and Market Share by Manufacturers
8.3 UK Viral-Vectored Vaccines Sales and Market Share by Type
8.4 UK Viral-Vectored Vaccines Sales and Market Share by Application

9 RUSSIA VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Viral-Vectored Vaccines Sales and Value (2012-2017)
  9.1.1 Russia Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  9.1.2 Russia Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Viral-Vectored Vaccines Sales Price Trend (2012-2017)
9.2 Russia Viral-Vectored Vaccines Sales and Market Share by Manufacturers
9.3 Russia Viral-Vectored Vaccines Sales and Market Share by Type
9.4 Russia Viral-Vectored Vaccines Sales and Market Share by Application

10 ITALY VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Viral-Vectored Vaccines Sales and Value (2012-2017)
  10.1.1 Italy Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  10.1.2 Italy Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Viral-Vectored Vaccines Sales Price Trend (2012-2017)
10.2 Italy Viral-Vectored Vaccines Sales and Market Share by Manufacturers
10.3 Italy Viral-Vectored Vaccines Sales and Market Share by Type
10.4 Italy Viral-Vectored Vaccines Sales and Market Share by Application

11 SPAIN VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Viral-Vectored Vaccines Sales and Value (2012-2017)
  11.1.1 Spain Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  11.1.2 Spain Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Viral-Vectored Vaccines Sales Price Trend (2012-2017)
11.2 Spain Viral-Vectored Vaccines Sales and Market Share by Manufacturers
11.3 Spain Viral-Vectored Vaccines Sales and Market Share by Type
11.4 Spain Viral-Vectored Vaccines Sales and Market Share by Application

12 BENELUX VIRAL-VECTORED VACCINES (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Viral-Vectored Vaccines Sales and Value (2012-2017)
  12.1.1 Benelux Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Viral-Vectored Vaccines Sales Price Trend (2012-2017)
12.2 Benelux Viral-Vectored Vaccines Sales and Market Share by Manufacturers
12.3 Benelux Viral-Vectored Vaccines Sales and Market Share by Type
12.4 Benelux Viral-Vectored Vaccines Sales and Market Share by Application

13 EUROPE VIRAL-VECTORED VACCINES MANUFACTURERS ANALYSIS

13.1 Bayer HealthCare AG (Germany)
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Biogenesis-Bago (Argentina)
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Boehringer Ingelheim GmbH (Germany)
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Ceva Sante Animale (France)
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Heska Corporation (US)
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Indian Immunologicals Ltd (India)
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Lohmann Animal Health (US)
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Merck Animal Health (US)
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Merial Ltd. (US)
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview
…

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE VIRAL-VECTORED VACCINES MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Viral-Vectored Vaccines Market Forecast by Type (2017-2021)
15.9 Europe Viral-Vectored Vaccines Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Viral-Vectored Vaccines
Table Classification of Viral-Vectored Vaccines
Figure Europe Sales Market Share of Viral-Vectored Vaccines by Type in 2015
Table Application of Viral-Vectored Vaccines
Figure Europe Sales Market Share of Viral-Vectored Vaccines by Application in 2015
Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure France Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure UK Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Figure Europe Viral-Vectored Vaccines Sales and Growth Rate (2012-2021)
Figure Europe Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)
Table Europe Viral-Vectored Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Europe Viral-Vectored Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Viral-Vectored Vaccines Sales Share by Manufacturers
Figure 2016 Viral-Vectored Vaccines Sales Share by Manufacturers
Table Europe Viral-Vectored Vaccines Revenue by Manufacturers (2015 and 2016)
Table Europe Viral-Vectored Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Viral-Vectored Vaccines Revenue Share by Manufacturers
Table 2016 Europe Viral-Vectored Vaccines Revenue Share by Manufacturers
Table Europe Viral-Vectored Vaccines Sales and Market Share by Type (2012-2017)
Table Europe Viral-Vectored Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Viral-Vectored Vaccines by Type (2012-2017)
Figure Europe Viral-Vectored Vaccines Sales Growth Rate by Type (2012-2017)
Table Europe Viral-Vectored Vaccines Revenue and Market Share by Type (2012-2017)
Table Europe Viral-Vectored Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral-Vectored Vaccines by Type (2012-2017)
Figure Europe Viral-Vectored Vaccines Revenue Growth Rate by Type (2012-2017)
Table Europe Viral-Vectored Vaccines Sales and Market Share by Countries (2012-2017)
Table Europe Viral-Vectored Vaccines Sales Share by Countries (2012-2017)
Figure Sales Market Share of Viral-Vectored Vaccines by Countries (2012-2017)
Table Europe Viral-Vectored Vaccines Revenue and Market Share by Countries (2012-2017)
Table Europe Viral-Vectored Vaccines Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Viral-Vectored Vaccines by Countries (2012-2017)
Table Europe Viral-Vectored Vaccines Sales and Market Share by Application (2012-2017)
Table Europe Viral-Vectored Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Viral-Vectored Vaccines by Application (2012-2017)
Figure Germany Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure Germany Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table Germany Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Germany Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Germany Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Germany Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Germany Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Germany Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure France Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure France Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure France Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table France Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table France Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table France Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table France Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table France Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table France Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure UK Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure UK Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure UK Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table UK Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table UK Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table UK Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table UK Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table UK Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table UK Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Russia Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure Russia Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table Russia Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Russia Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Russia Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Russia Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Russia Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Russia Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Italy Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure Italy Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table Italy Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Italy Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Italy Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Italy Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Italy Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Italy Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Spain Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure Spain Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table Spain Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Spain Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Spain Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Spain Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Spain Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Spain Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Figure Benelux Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)
Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)
Figure Benelux Viral-Vectored Vaccines Sales Price Trend (2012-2017)
Table Benelux Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Sales by Type (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Market Share by Type (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Sales by Application (2015 and 2016)
Table Benelux Viral-Vectored Vaccines Market Share by Application (2015 and 2016)
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales Market Share (2012-2017)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales Market Share (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales Market Share (2012-2017)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales Market Share (2012-2017)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Heska Corporation (US) Viral-Vectored Vaccines Sales Market Share (2012-2017)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales Market Share (2012-2017)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lohmann Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2012-2017)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2012-2017)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merial Ltd. (US) Viral-Vectored Vaccines Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral-Vectored Vaccines
Figure Manufacturing Process Analysis of Viral-Vectored Vaccines
Figure Viral-Vectored Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral-Vectored Vaccines
Table Distributors/Traders List
Figure Germany Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure France Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure France Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure UK Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure UK Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table Europe Viral-Vectored Vaccines Sales Forecast by Type (2017-2021)
Table Europe Viral-Vectored Vaccines Sales Forecast by Application (2017-2021)